| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1984) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | G2M7P15E5P |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| None | Osmotic laxative | BNF |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetes Mellitus | 3 | D003920 | ClinicalTrials |
| Hepatitis C | 3 | D006526 | ClinicalTrials |
| Hepatitis C, Chronic | 3 | D019698 | ClinicalTrials |
| Colonic Neoplasms | 3 | D003110 | ClinicalTrials |
| Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
| Clostridium Infections | 2 | D003015 | ClinicalTrials |
| Crohn Disease | 2 | D003424 | ClinicalTrials |
| Peripheral Nerve Injuries | 1 | D059348 | ClinicalTrials |
Related Entries
Adverse Reactions
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1201479 |
| FDA SRS | G2M7P15E5P |
CONTENTS